Roger Mouawad
- Molecular Biology
- Oncology top 10%
- Immunology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- David KhayatD. KhayatClaude SoubraneJean‐Philippe SpanoOlivier RixeGabriel G. MaloufXiaoping SuC. Soubrane
- Topics
- Angiogenesis and VEGF in Cancer (11 papers)Renal cell carcinoma treatment (10 papers)Renal and related cancers (9 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- FranceUnited StatesChina
In The Last Decade
Roger Mouawad
53 papers receiving 940 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 523
- Oncology 308
- Immunology 208
- Cancer Research 177
- Pulmonary and Respiratory Medicine 155
Countries citing papers authored by Roger Mouawad
This map shows the geographic impact of Roger Mouawad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Mouawad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Mouawad more than expected).
Fields of papers citing papers by Roger Mouawad
This network shows the impact of papers produced by Roger Mouawad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Mouawad. The network helps show where Roger Mouawad may publish in the future.
Co-authorship network of co-authors of Roger Mouawad
This figure shows the co-authorship network connecting the top 25 collaborators of Roger Mouawad. A scholar is included among the top collaborators of Roger Mouawad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Mouawad. Roger Mouawad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 4 | |
| 4 | 41 | |
| 5 | 38 | |
| 6 | 1 | |
| 7 | 39 | |
| 8 | 39 | |
| 9 | 12 | |
| 10 | 28 | |
| 11 | 40 | |
| 12 | 40 | |
| 13 | 35 | |
| 14 | 35 | |
| 15 | 8 | |
| 16 | 45 | |
| 17 | 16 | |
| 18 | 11 | |
| 19 | 1 | |
| 20 | 5 |
About Roger Mouawad
Roger Mouawad is a scholar working on Oncology, Molecular Biology and Immunology, having authored 57 papers that have together received 968 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (11 papers), Renal cell carcinoma treatment (10 papers) and Renal and related cancers (9 papers). The work is most often cited by research in Cancer Research (177 citations), Oncology (308 citations) and Immunology (208 citations). Roger Mouawad has collaborated with scholars based in France, United States and China. Frequent co-authors include David Khayat, D. Khayat, Claude Soubrane, Jean‐Philippe Spano, Olivier Rixe, Gabriel G. Malouf, Xiaoping Su, C. Soubrane, Jean‐Baptiste Méric and Judith Michels. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.